Project Synopsis:

Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Project Description:

Datamonitors' CardioVascular BioTherapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by CardioVascular BioTherapeutics, Inc. since January 2007.

Scope:

– Provides intelligence on CardioVascular BioTherapeutics, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
– Detailed reports of various financial transactions undertaken by CardioVascular BioTherapeutics, Inc. and its subsidiaries since 2007.
– Information about key financial and legal advisors for CardioVascular BioTherapeutics, Inc.'s financial deals transactions.
– Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Highlights:

This report includes CardioVascular BioTherapeutics, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by CardioVascular BioTherapeutics, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Reasons to Purchase:

– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
– Form an independent opinion about CardioVascular BioTherapeutics, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
– Track your competitors’ business structure and growth strategies.

Table Of Contents

TABLE OF CONTENTS

COMPANY OVERVIEW AND KEY FACTS
PARTNERSHIP
--Partnership - Overview
--Partnership - Deal reports
CAPITAL RAISING
--Capital Raising - Overview
--Capital Raising - Deal reports

APPENDIX
--About Datamonitor Financial Deals Database
--Deal Definition and Methodology
--About Datamonitor
--Datamonitor Professional Services Knowledge Center

LIST OF TABLES

--CardioVascular BioTherapeutics activity by deal type - volume (2010-TTM2011)
--CardioVascular BioTherapeutics activity by deal type - volume (2007 -YTD2011)
--CardioVascular BioTherapeutics legal advisor ranking by value ($m)
--Top Deals(2007 -YTD2011)
--CardioVascular BioTherapeutics targets and partners (2007 -YTD2011)
--CardioVascular BioTherapeutics partnership volume and value trend (2007-YTD2011)
--CardioVascular BioTherapeutics partnership trend by key deal type (2007-YTD2011)
--CardioVascular BioTherapeutics capital raising volume and value trend (2007-YTD2011)
--CardioVascular BioTherapeutics capital raising by deal type (2007-YTD2011)

LIST OF FIGURES

--CardioVascular BioTherapeutics activity by deal type - volume (trailing twelve months (TTM))
--CardioVascular BioTherapeutics activity by deal type - volume (2007-YTD2011)
--CardioVascular BioTherapeutics partnership volume and value trend (2007-YTD2011)
--CardioVascular BioTherapeutics partnership trend by key deal type (2007-YTD2011)
--CardioVascular BioTherapeutics capital raising volume and value trend (2007-YTD2011)
--CardioVascular BioTherapeutics capital raising by deal type (2007-YTD2011)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Inflammation - Pipeline Review, H1 2014

Inflammation - Pipeline Review, H1 2014

  • $ 2 500
  • Company report
  • June 2014
  • by Global Markets Direct

Inflammation - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Inflammation - Pipeline Review, H1 2014', provides an overview of the Inflammation's therapeutic pipeline. This report provides ...

Corcept Therapeutics Incorporated - Product Pipeline Review - 2014

Corcept Therapeutics Incorporated - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • April 2014
  • by Global Markets Direct

Corcept Therapeutics Incorporated - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Corcept Therapeutics Incorporated - Product Pipeline Review - 2014', provides an overview of the Corcept ...

Pharmaceutical in United States: ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review – H2 2011

Pharmaceutical in United States: ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

- Product Pipeline Review - H2 2011” provides a detailed overview on the ImmunoCellular Therapeutics, Ltd.’s research and development focus. The report includes information on current developmental ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.